You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-620

Showing 26 - 50 of 387
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +54 more
Jan 26, 2023

Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))

Not yet recruiting
  • Endometriosis
  • Moderate to Severe Endometriosis-associated Pain
  • BG2109 100mg
  • +5 more
  • (no location specified)
Jun 6, 2023

Primary Invasive Malignant Tumor of Female Breast, Carcinoma Breast, Breast Cancer Female Trial in United States

Completed
  • Primary Invasive Malignant Neoplasm of Female Breast
  • +6 more
  • Investigational Imaging device
  • AVB-620
  • San Diego, California
  • +12 more
Jun 10, 2021

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021

Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)

Active, not recruiting
Has Results
  • Endometriosis
  • Estradiol/Norethindrone Acetate
  • +3 more
  • Birmingham, Alabama
  • +196 more
Feb 14, 2022

Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)

Completed
  • Lymphoma, Mantle-Cell
  • Recurrent Lymphoma, Mantle-Cell
  • ABT-199 and Ibrutinib Combination
  • Duarte, California
  • +3 more
May 22, 2022

ASPIRIN: Neurodevelopmental Follow-up Trial

Completed
  • Neurodevelopmental Abnormality
  • Birmingham, Alabama
  • +13 more
Jun 24, 2022

Sport-related Concussion Trial in Plano (Screen Time Restriction (ST-Restricted), Aerobic Exercise (AE), Screen-time restricted

Recruiting
  • Sport-related Concussion
  • Screen Time Restriction (ST-Restricted)
  • +3 more
  • Plano, Texas
    Children's Health - Andrews Institute
Aug 22, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in Italy (Venetoclax)

Active, not recruiting
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • Aviano, Italy
  • +12 more
Dec 20, 2022

Hepatitis C, Chronic Trial (ABT-450/r, ABT-267, Ribavirin (RBV))

Completed
Has Results
  • Hepatitis C, Chronic
  • (no location specified)
Jul 28, 2021

Osteoarthritis Trial in Lund (Optivac, Optipac, Arcom (Exceed cup))

Active, not recruiting
  • Osteoarthritis
  • Optivac
  • +4 more
  • Lund, Sweden
    Deot of Orthopedics, Skane University Hospital, Lund University
Apr 26, 2022

Exceed ABT Acetabular Cup Cementless System

Completed
  • Osteoarthritis
  • +2 more
    • (no location specified)
    May 9, 2022

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Chronic Lymphocytic Leukemia Trial in Houston (Ibrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2022

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Coronary Artery Disease Trial in Australia, Taiwan, United States (ABT NG DES 48 EECSS)

    Active, not recruiting
    • Coronary Artery Disease
    • ABT NG DES 48 EECSS
    • Scottsdale, Arizona
    • +28 more
    Mar 28, 2022

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)

    Recruiting
    • Ischemia Reperfusion Injury
    • Conjugated Estrogen
    • Normal saline
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Sep 22, 2022

    Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021